🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,931 results for “The” Clear

  1. morphine

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    approved small molecule completed

    1 trial

  2. mouse nerve growth factor

    The First People's Hospital of Lianyungang

    Cerebral Small Vessel Diseases

    approved small molecule active

    1 trial

  3. mycophenolate mofetil

    United Therapeutics Europe Ltd

    IGA Nephropathy

    approved small molecule completed

    1 trial

  4. neoadjuvant therapy

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma Resectable

    approved other active

    1 trial

  5. physiotherapeutic treatment

    Universal Integrated

    Morquio's Disease

    approved other terminated

    1 trial

  6. prescribing anapproved drug, examination

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule active

    1 trial

  7. profound neuromuscular blockade

    The First People's Hospital of Lianyungang

    Profound Muscle Relaxation

    approved small molecule active

    1 trial

  8. quetiapine fumarate tablet (Seroquel)

    The First People's Hospital of Lianyungang

    Bipolar Disorder

    approved small molecule active

    1 trial

  9. recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Healthy

    approved small molecule completed

    1 trial

  10. recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  11. rhGM-CSF group

    The First People's Hospital of Lianyungang

    Mycoses

    approved small molecule completed

    1 trial

  12. rhTPO

    The First People's Hospital of Lianyungang

    Primary Immune Thrombocytopenia

    approved small molecule active

    1 trial

  13. rhTPO

    The First People's Hospital of Lianyungang

    Thrombocytopenia

    approved small molecule active

    1 trial

  14. rituximab combined with corticosteroids

    The First People's Hospital of Lianyungang

    Primary Membranous Nephropathy

    approved small molecule active

    1 trial

  15. ropivacaine

    The First People's Hospital of Lianyungang

    Injury of Upper Limb

    approved small molecule completed

    1 trial

  16. semaglutide combined with metformin

    The First People's Hospital of Lianyungang

    Osteoporosis

    approved small molecule active

    1 trial

  17. sodium iodide

    United Therapeutics Europe Ltd

    Transient Hypothyroxinemia

    approved small molecule completed

    1 trial

  18. sodium zirconium cyclic silicate

    The First People's Hospital of Lianyungang

    Potassium Imbalance

    approved small molecule active

    1 trial

  19. tasimelteon 20 mg capsule

    Vanda Pharmaceuticals Netherlands B.V.

    Non-24-Hour-Sleep-Wake Disorder

    approved small molecule completed

    1 trial

  20. theophylline

    Takeda

    Healthy

    approved small molecule completed

    1 trial

  21. ticagrelor

    The First People's Hospital of Lianyungang

    Inflammation

    approved small molecule completed

    1 trial

  22. transdermal nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule active

    1 trial

  23. treprostinil sodium

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    1 trial

  24. treprostinil sodium

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources